Berberine
Berberine can lower glucose and may confound glucose interpretation if an unapproved metabolic peptide is used.
Recommendation: Avoid unsupervised stacking; monitor glucose only under clinician care.
Peptide ·Insufficient evidence ·Reviewed May 2026
HGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone marketed for fat loss and lipolysis. It is not FDA-approved for any indication, is prohibited in sport as a GH fragment, and human fat-loss efficacy is not established. Published support is mainly adipocyte and animal work, with limited and mixed human development data for related AOD9604 formulations.
The bottom line
Evidence rating insufficient. Most-documented uses: experimental anti-lipogenic activity in adipocyte models, related aod9604 studied for obesity, no approved human fat-loss benefit. 3 sources indexed (1993–2013), with 3 interaction records on file.
Core mechanism
The fragment corresponds to a C-terminal region of growth hormone reported to reduce lipogenesis and influence fat-cell lipid handling in experimental systems. It is not full growth hormone and should not be used to treat GH deficiency. Any injectable research product carries sterility, identity, and dosing uncertainty.3,2
Peptides are generally not reliably orally bioavailable unless a specific studied oral formulation is used. Human use of research-grade products is not appropriate.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Laboratory Research Reagent.
Research-market pricing is not a dosing recommendation; human use is not FDA-approved unless specifically stated. Updated 2026-06-04.
Dose: No FDA-approved dose
Timing: Not applicable
Human fat-loss evidence is inadequate and product quality is a major concern.
Dose: Protocol-specific laboratory concentration
Timing: Laboratory protocol only
Not a human supplementation goal.
Dose: No approved dose
Timing: Not applicable
GH fragments are prohibited in sport.
What to test, the optimal window inside the conventional range, and how long a response takes.
No reliable clinical direction is established; monitor if any endocrine-active product exposure occurs.
Do not use glucose monitoring to justify unsupervised peptide use.
Unexpected IGF-1 elevation suggests mislabeling or other GH-axis exposure.3
Routine IGF-1 is not a safety guarantee.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Marketed mechanism is adipocyte lipid handling, but human efficacy is not established.2
Use evidence-based obesity care.
Related GH-fragment trials did not establish approved weight-loss therapy.2
Do not use in place of approved treatments.
Mechanistic claims are speculative for humans.
Monitor metabolic disease through standard care.
Berberine can lower glucose and may confound glucose interpretation if an unapproved metabolic peptide is used.
Recommendation: Avoid unsupervised stacking; monitor glucose only under clinician care.
Alpha-lipoic acid may improve insulin sensitivity and obscure adverse glucose effects from peptide exposure.
Recommendation: Avoid combining for self-directed fat-loss protocols.
Weight-loss supplement stacking can increase adverse-effect burden while efficacy remains unproven.
Recommendation: Avoid multi-agent weight-loss stacks, especially with liver disease, anxiety, or hypertension.
Numbered references. Citations throughout the page link here.
Human evidence did not lead to approval
Effects depended on animal model
Reduced lipogenesis in experimental preparations
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.